NCT05172310
- Conditions
- Adnexal Diseases, Bile Duct Diseases, Bile Duct Neoplasms, +29 more
- Locations
-
- Karolinska University Hospital Huddinge Stockholm, Sweden
Clinical trial condition
Carcinoma, Ovarian Epithelial
Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.
539 public trials
64 recruiting studies
Carcinoma, Ovarian Epithelial trial results
NCT04834544
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
Recruiting
Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer
NCT03025477
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Centre Georges François Leclerc Dijon, France
- Institut Hospitalier Franco-Britannique Levallois-Perret, France
- Groupe Hospitalier Diaconesses Croix Saint Simon Paris, France
- Hôpital Saint Antoine Paris, France
NCT04063527
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Aichi Medical University Hospital Nagakute-shi, Aichi-ken, Japan
- Tosei General Hospital Seto-shi, Aichi-ken, Japan
- Fujita Health University Hospital Toyoake-shi, Aichi-ken, Japan
- Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori, Japan
Not yet recruiting
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
NCT07265739
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Not yet recruiting
Homologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-stage Epithelial Ovarian Cancer in Italy
NCT07825181
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Italy
Not yet recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- Research Site Anchorage, Alaska, United States
- Research Site Columbia, Maryland, United States
- Research Site Detroit, Michigan, United States
- Research Site Albany, New York, United States
Not yet recruiting
Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers
NCT07811271
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
Not specified
Not yet recruiting
89Zr-DFO-Mirvetuximab PET/CT Imaging for Companion Diagnosis and Response Evaluation in Ovarian Cancer
NCT07790939
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
Not specified
Not yet recruiting
Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer
NCT07776171
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China